Cell Lines from Kidney Proximal Tubules of a Patient with Lowe Syndrome Lack OCRL Inositol Polyphosphate 5-Phosphatase and Accumulate Phosphatidylinositol 4,5-Bisphosphate*

The protein product of the gene that when mutated is responsible for Lowe syndrome, or oculocerebrorenal syndrome (OCRL), is an inositol polyphosphate 5-phosphatase. It has a marked preference for phosphatidylinositol 4,5-bisphosphate although it hydrolyzes all four of the known inositol polyphosphate 5-phosphatase substrates: inositol 1,4,5-trisphosphate, inositol 1,3,4,5-tetrakisphosphate, phosphatidylinositol 4,5-bisphosphate, and phosphatidylinositol 3,4,5-trisphosphate. The enzyme activity of this protein is determined by a region of 672 out of a total of 970 amino acids that is homologous to inositol polyphosphate 5-phosphatase II. Cell lines from kidney proximal tubules of a patient with Lowe syndrome and a normal individual were used to study the function of OCRL. The cells from the Lowe syndrome patient lack OCRL protein. OCRL is the major phosphatidylinositol 4,5-bisphosphate 5-phosphatase in these cells. As a result, these cells accumulate phosphatidylinositol 4,5-bisphosphate even though at least four other inositol polyphosphate 5-phosphatase isozymes are present in these cells. OCRL is associated with lysosomal membranes in control proximal tubule cell lines suggesting that OCRL may function in lysosomal membrane trafficking by regulating the specific pool of phosphatidylinositol 4,5-bisphosphate that is associated with lysosomes.

[1]  Gregory J. Parker,et al.  Phosphatidylinositol-4-phosphate 5-Kinase Isozymes Catalyze the Synthesis of 3-Phosphate-containing Phosphatidylinositol Signaling Molecules* , 1997, The Journal of Biological Chemistry.

[2]  R. Nussbaum,et al.  Spectrum of mutations in the OCRL1 gene in the Lowe oculocerebrorenal syndrome. , 1997, American journal of human genetics.

[3]  D. Pot,et al.  Signaling Inositol Polyphosphate-5-phosphatase , 1997, The Journal of Biological Chemistry.

[4]  P. Majerus,et al.  Phosphorylation of Platelet Pleckstrin Activates Inositol Polyphosphate 5-Phosphatase I* , 1997, The Journal of Biological Chemistry.

[5]  W. Balch,et al.  AP-2-containing clathrin coats assemble on mature lysosomes , 1996, The Journal of cell biology.

[6]  M. Osborne,et al.  The Inositol 5′-Phosphatase SHIP Binds to Immunoreceptor Signaling Motifs and Responds to High Affinity IgE Receptor Aggregation* , 1996, The Journal of Biological Chemistry.

[7]  C. Mitchell,et al.  Regulation of second messengers by the inositol polyphosphate 5-phosphatases. , 1996, Biochemical Society transactions.

[8]  X. Pesesse,et al.  The family of inositol and phosphatidylinositol polyphosphate 5-phosphatases. , 1996, Biochemical Society transactions.

[9]  J. Falck,et al.  A Functional Phosphatidylinositol 3,4,5-Trisphosphate/Phosphoinositide Binding Domain in the Clathrin Adaptor AP-2 α Subunit. IMPLICATIONS FOR THE ENDOCYTIC PATHWAY* , 1996, The Journal of Biological Chemistry.

[10]  P. Majerus.  Inositols do it all. , 1996, Genes & development.

[11]  S. Schiffmann,et al.  Post-translational Modification of Human Brain Type I Inositol-1,4,5-trisphosphate 5-Phosphatase by Farnesylation (*) , 1996, The Journal of Biological Chemistry.

[12]  Barbara J. Reaves,et al.  The effect of wortmannin on the localisation of lysosomal type I integral membrane glycoproteins suggests a role for phosphoinositide 3-kinase activity in regulating membrane traffic late in the endocytic pathway. , 1996, Journal of cell science.

[13]  D. Pot,et al.  Multiple forms of an inositol polyphosphate 5-phosphatase form signaling complexes with Shc and Grb2 , 1996, Current Biology.

[14]  P. De Camilli,et al.  Phosphoinositides as Regulators in Membrane Traffic , 1996, Science.

[15]  P. Majerus,et al.  The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphate 5-phosphatase. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[16]  S. Suchy,et al.  Lowe syndrome, a deficiency of phosphatidylinositol 4,5-bisphosphate 5-phosphatase in the Golgi apparatus. , 1995, Human molecular genetics.

[17]  P. Bird,et al.  Tissue distribution and intracellular localisation of the 75-kDa inositol polyphosphate 5-phosphatase. , 1995, European journal of biochemistry.

[18]  R. Nussbaum,et al.  The oculocerebrorenal syndrome gene product is a 105-kD protein localized to the Golgi complex. , 1995, American journal of human genetics.

[19]  C. Mitchell,et al.  Phosphatidylinositol 3,4,5‐trisphosphate is a substrate for the 75 kDa inositol polyphosphate 5‐phosphatase and a novel 5‐phosphatase which forms a complex with the p85/p110 form of phosphoinositide 3‐kinase. , 1995, The EMBO journal.

[20]  P. Majerus,et al.  The protein deficient in Lowe syndrome is a phosphatidylinositol-4,5-bisphosphate 5-phosphatase. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[21]  P. Majerus,et al.  Properties of Type II Inositol Polyphosphate 5-Phosphatase (*) , 1995, The Journal of Biological Chemistry.

[22]  P. Majerus,et al.  Hydrolysis of phosphatidylinositol 3,4-bisphosphate by inositol polyphosphate 4-phosphatase isolated by affinity elution chromatography. , 1994, The Journal of biological chemistry.

[23]  C. Mitchell,et al.  Identification and characterization of the phosphatidylinositol-(4, 5)-bisphosphate 5-phosphatase in human platelets. , 1994, The Journal of biological chemistry.

[24]  G. Griffiths,et al.  Evidence for retrograde traffic between terminal lysosomes and the prelysosomal/late endosome compartment. , 1994, Journal of cell science.

[25]  H. Tsuji,et al.  Cycling of two endogenous lysosomal membrane proteins, lamp-2 and acid phosphatase, between the cell surface and lysosomes in cultured rat hepatocytes. , 1993, Journal of biochemistry.

[26]  R. Nussbaum,et al.  Nonsense mutations in the OCRL-1 gene in patients with the oculocerebrorenal syndrome of Lowe. , 1993, Human molecular genetics.

[27]  R. Nussbaum,et al.  The Lowe's oculocerebrorenal syndrome gene encodes a protein highly homologous to inositol polyphosphate-5-phosphatase , 1992, Nature.

[28]  J. Keen,et al.  Interaction of phosphoinositide cycle intermediates with the plasma membrane-associated clathrin assembly protein AP-2. , 1991, The Journal of biological chemistry.

[29]  E. Unanue,et al.  Liposome-encapsulated antigens are processed in lysosomes, recycled, and presented to T cells , 1991, Cell.

[30]  B. Storrie,et al.  Osmotic swelling of endocytic compartments induced by internalized sucrose is restricted to mature lysosomes in cultured mammalian cells. , 1991, Experimental cell research.

[31]  P. Majerus,et al.  Pathway for the formation of D-3 phosphate containing inositol phospholipids in intact human platelets. , 1990, Journal of Biological Chemistry.

[32]  P. Libby,et al.  PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells , 1989, Cell.

[33]  P. Majerus,et al.  Isolation of a phosphomonoesterase from human platelets that specifically hydrolyzes the 5-phosphate of inositol 1,4,5-trisphosphate. , 1985, The Journal of biological chemistry.

[34]  B. Ames,et al.  The role of polyamines in the neutralization of bacteriophage deoxyribonucleic acid. , 1960, The Journal of biological chemistry.

[35]  M. Terrey,et al.  Organic-aciduria, decreased renal ammonia production, hydrophthalmos, and mental retardation; a clinical entity. , 1952, A.M.A. American journal of diseases of children.